Apply for spring semester scholarship today!
Female With Permanent Hair Loss Stock Photo

Side Effects From Taking Taxotere®?

What's Your Case Really Worth?

"*" indicates required fields

Name*
Hidden
Hidden

Connect with us at Ken Nunn! By entering your phone number and submitting your information, you consent to receiving marketing communications via phone calls and SMS text messages from Ken Nunn and/or our associated partners, using an Automated Telephone Dialing System (ATDS). Message and data rates may apply. You can opt out of text messages at any time by texting STOP. By clicking Submit, you agree to our Terms and Conditions. Please be sure to review our Privacy Policy.

If you live in Indiana, received the cancer treatment Taxotere® and permanently lost your hair, you may be eligible to file a claim to receive financial compensation. Hold the drug maker responsible. Don’t wait. Contact Ken Nunn now to schedule your free case review. Call now at 1-800-CALL-KEN. Taxotere claims can only be filed for a limited amount of time. Don’t wait or you may lose your right to file.

What is Taxotere®?

Taxotere® (docetaxel) is a chemotherapy drug manufactured by Sanofi-Aventis. It was originally developed to treat breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer, and metastatic prostate cancer. Although most chemotherapy drugs do come with a risk of hair loss, Taxotere® is different because many patients developed alopecia. Alopecia is a skin disorder where hair does not grow on a part of the body where it normally grows.

How Long Has Taxotere® Been Around?

Taxotere® was approved by the FDA for use in certain cancer diagnoses in 1999. Taxotere® is provided during a one hour-long infusion every three to four weeks. By 2005, women began reporting permanent hair loss. Many plaintiffs of the lawsuit stated that had they known that alopecia was a permanent potential side effect, they would have opted for a different chemotherapy drug.

Lawsuits Filed Against Manufacturer

Lawsuits against Sanofi-Aventis allege that cancer patients developed alopecia or neutropenic enterocolitis, which is an inflammation located at the start of the large intestine.  Neutropenic enterocolitis is often deadly.

In December 2015, the FDA acknowledged that Taxotere® can cause alopecia and a warning label is now required. Yet, this news comes as too little, too late for many people who’ve already filed lawsuits against the manufacturer. There are likely more people who have yet to come forward.

A cancer diagnosis on its own is devastating. Treatment is difficult for the patient and their family. The cost of treatment for cancer, whether the patient has insurance or not can be financially devastating. Loss of income, secondary infections, and losing time with loved ones makes cancer recovery difficult. Choosing a chemotherapy drug like Taxotere® should offer hope and not fears of permanent hair loss and dangerous infections.

Contact Ken Nunn Law Offices Today!

If you or your loved one received the cancer treatment Taxotere® and suffered from alopecia, call Ken Nunn now. Don’t wait. These claims are time sensitive. Waiting could mean that you lose your right to file a claim. You may be entitled to financial compensation including medical care and pain and suffering. If you lost a loved one to neutropenic enterocolitis and they took Taxotere®, you may be entitled to financial compensation for wrongful death, medical expenses, lost wages, and pain and suffering. Call Ken Nunn right now at 1-800-CALL-KEN or use our contact form. The consultation is free and there’s no obligation. Do not stop using this drug without first consulting your physician.